GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹273 Cr | ₹293 Cr | ₹222 Cr | ₹192 Cr | ₹205 Cr |
What is the latest Sundry Debtors ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹273 Cr |
| Mar2025 | ₹293 Cr |
| Mar2024 | ₹222 Cr |
| Mar2023 | ₹192 Cr |
| Mar2022 | ₹205 Cr |
How is Sundry Debtors of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹273 Cr | -6.64 | |
| Mar2025 | ₹293 Cr | 31.75 | |
| Mar2024 | ₹222 Cr | 15.43 | |
| Mar2023 | ₹192 Cr | -6.27 | |
| Mar2022 | ₹205 Cr | - | |
Compare Sundry Debtors of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹42,463.5 Cr | 2.9% | 13.9% | -24.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.8% | 8.3% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,316.0 Cr | 7.1% | 9% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,316.0 Cr | 2% | 12.1% | 49.6% | Stock Analytics | |
| CIPLA | ₹115,477.0 Cr | -0.7% | 4.1% | -3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,156.0 Cr | -1.7% | -4.2% | -3.1% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 2.9% |
13.9% |
-24.7% |
| SENSEX | 0.6% |
1.2% |
-7.8% |
You may also like the below Video Courses